Europe Faces Competition for Pharma Investment, AstraZeneca CEO Says
Dow Jones
Jul 27
1230 GMT - Europe is increasingly competing with emerging markets to attract investments from the pharmaceutical industry, AstraZeneca CEO Pascal Soriot says on a call with reporters. Investments will follow market access to the most innovative drugs, and countries that five or ten years ago would have approved medicines later than Europe are now moving faster, he says. Many countries around the world want pharma research-and-development investments because of their economic benefits, and Europe faces huge competition from emerging markets, Soriot adds. Shares rise 1.75%.(adria.calatayud@wsj.com)
(END) Dow Jones Newswires
July 27, 2026 08:31 ET (12:31 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.